Across the recent three months, 6 analysts have shared their insights on Agilent Technologies A, expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 1 | 3 | 2 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 3 | 1 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 1 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.83, a high estimate of $155.00, and a low estimate of $90.00. Witnessing a positive shift, the current average has risen by 12.46% from the previous average price target of $113.67.
Breaking Down Analyst Ratings: A Detailed Examination
An in-depth analysis of recent analyst actions unveils how financial experts perceive Agilent Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Ian Zaffino | Oppenheimer | Raises | Outperform | $90.00 | $67.00 |
| Patrick Donnelly | Citigroup | Raises | Neutral | $145.00 | $130.00 |
| Elizabeth Garcia | UBS | Raises | Neutral | $155.00 | $130.00 |
| Ross Muken | Evercore ISI Group | Lowers | In-Line | $132.00 | $135.00 |
| Jack Meehan | Barclays | Raises | Underweight | $125.00 | $120.00 |
| Jack Meehan | Barclays | Raises | Underweight | $120.00 | $100.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Agilent Technologies. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Agilent Technologies compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Agilent Technologies's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
For valuable insights into Agilent Technologies's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Agilent Technologies analyst ratings.
Unveiling the Story Behind Agilent Technologies
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
A Deep Dive into Agilent Technologies's Financials
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Agilent Technologies's revenue growth over a period of 3 months has faced challenges. As of 31 January, 2024, the company experienced a revenue decline of approximately -5.58%. This indicates a decrease in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Agilent Technologies's net margin is impressive, surpassing industry averages. With a net margin of 20.99%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Agilent Technologies's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.78% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Agilent Technologies's ROA stands out, surpassing industry averages. With an impressive ROA of 3.21%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.41, Agilent Technologies adopts a prudent financial strategy, indicating a balanced approach to debt management.
What Are Analyst Ratings?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
